We are live on
!
Find out more
NanoViricides
NNVC
NNVC
45 hedge funds and large institutions have $3.85M invested in NanoViricides in 2017 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
40% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 5
2% more funds holding
Funds holding: 44 → 45 (+1)
0% more ownership
Funds ownership: 0.3% → 0.3% (+0%)
14% less capital invested
Capital invested by funds: $4.49M → $3.85M (-$637K)
Holders
45
Holders Change
+1
Holders Change %
+2.27%
% of All Funds
1.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
7
Reduced
5
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$75.7K |
| 2 |
VF
Virtu Financial
New York
|
+$45.2K |
| 3 |
Renaissance Technologies
New York
|
+$44.8K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$44.8K |
| 5 |
Lido Advisors
Los Angeles,
California
|
+$16.1K |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$16K |
| 2 |
Goldman Sachs
New York
|
-$15.8K |
| 3 |
Group One Trading
Chicago,
Illinois
|
-$14K |
| 4 |
Creative Planning
Overland Park,
Kansas
|
-$11K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$9.4K |
